Pyraclostrobin is a synthetic inhibitor-type fungicide widely used in agriculture. It is used as a soil fungicide for several years. It is used to control major plant pathogens including Septoria tritici, Puccinia spp. and Pyrenophora teres Research studies have shown that it can inhibit the growth of several types of fungi. Several key activities have been attributed to pyraclostrobin. First, it serves as an organic fertilizer that improves soil fertility. Second, the compounds in it suppress the root system of susceptible plants by reducing plant root vigor. Third, it contains aromatic chemicals that inhibit the growth of certain airborne plant allergens.
In Australia, the major uses of pyraclostrobin are seed coatings, tobacco crops, sugar cane, and soya beans. In the U.S, usage of carbamate-free varieties of this agent has become widespread due to the restrictions on the use of some toxic chemicals. Two major applications are for livestock feeds and for treating golf courses, where the use of toxic pesticides is prohibited. Pyraclostrobin has been extensively evaluated in animals including sheep, rats and mice. It showed promising results as an anti-allergic (anti-allergen) for animals. The sensitivity of tested animals to standard GM maize was reduced compared with the controls.
Currently, there are indications that the toxicology properties of pyraclostrobin are unknown. For non-allergic (non-allergenic) exposure, there is no evidence of carcinogenicity or chronic exposure effects. The plant's other proposed uses are as preventive and secondary control for insect and fungal mites, to prevent the growth and spread of maize fungi and as a preventative and treatment for soil bacteria and yeasts. Apart from its ability to suppress plant growth and stop the growth of invading organisms, the chemical has no other systemic effects on humans. This is in contrast to the commonly used agricultural fungicides such as lindane, atrazine and methoxychlor, which when absorbed by humans cause a wide range of health problems including skin irritation, depression, asthma and liver disease.
No comments:
Post a Comment